Health Tip: Asbestos Tips For Homeowners

Title: Health Tip: Asbestos Tips For HomeownersCategory: Health NewsCreated: 7/9/2018 12:00:00 AMLast Editorial Review: 7/9/2018 12:00:00 AM
Source: MedicineNet Lungs General - Category: Respiratory Medicine Source Type: news

Related Links:

A novel clinical trial aiming to train the immune system to recognize and attack pleural mesothelioma tumor cells has opened with considerable optimism across five European countries. The randomized phase II/III study is designed to measure the efficacy and anti-tumor activity of MesoPher, a vaccine combining a patient’s own dendritic immune cells with a specially engineered cell line. The multicenter study, which is hoping for 235 participants, has opened in Antwerp, Belgium; Lille, France; Ancona, Italy; Amsterdam and Rotterdam, Netherlands and Leicester, England. “There is hope, a lot of hope, with this stud...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
We read with interest the article by Maisonneuve et al. [1] concerning Low-dose computed tomography screening for lung cancer in those with asbestos-exposure in the workplace.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
Conditions:   Advanced and/or Metastatic Solid Tumors;   Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer;   Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma Interventions:   Drug: INCMGA00012;   Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Carboplatin;   Drug: Paclitaxel Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 18 April 2019Source: The Annals of Thoracic SurgeryAuthor(s): Fernando Espinoza-Mercado, Jerald D. Borgella, David Berz, Rodrigo F. Alban, Ariella Sarkissian, Taryne A. Imai, Harmik J. SoukiasianAbstractBackgroundCurrent guidelines support cancer-directed surgery, chemotherapy or active surveillance for clinical stages 1 to 3 of epithelial Malignant Pleural Mesothelioma (MPM). Definitive chemotherapy is recommended for sarcomatoid/biphasic histologies. Our objective is to assess compliance with recommendations, measuring their impact on overall survival (OS).MethodsThe National Cancer Dat...
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Not a ban, rule would require agency review before use
Source: Chemical and Engineering News - Category: Chemistry Authors: Source Type: research
The Environmental Protection Agency issued a new regulation on Wednesday that will make it tougher to domestically manufacture, import or sell products made with asbestos, the toxic mineral that causes mesothelioma and other diseases. The regulation closes a loophole in the partial ban of asbestos that was legislated almost 30 years ago. It will strengthen the EPA’s ability to review and prohibit the use of a long list of asbestos products that are not banned but have been long abandoned by the industry. The ruling is part of a legislative process that requires the EPA to review its regulation of asbestos under the...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news
Conclusions Epidemiological studies have repeatedly helped identify definitive triggers for several diseases. As highlighted in this perspective report, previous studies strongly argue for the interplay between intrinsic factors and putative preventable extrinsic triggers/promoters for CTCL. Given the evidence of geographical regional clustering of CTCL patients, CTCL occurrence in unrelated family members and recent evidence implicating S. aureus in the pathogenesis/progression of CTCL, more research is needed to decipher the precise mechanism by which specific environmental exposures may be driving the pathogenesis of t...
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
Condition:   Mesothelioma Interventions:   Drug: Nivolumab Injection;   Drug: Ipilimumab Injection Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Respiratory Medicine